The market's healthcare sector is coming off a very bad year compared to the S&P 500. Relatively speaking, no sector has done worse except for of the telecoms. But not all healthcare stocks have been underperformers.

Healthcare, in fact, might be better considered under two separate groupings: 1) those old-line, mega market cap drug and equipment manufacturers, and 2) the younger, more explosive biotech and experimental drug companies.

Below we highlight both types - three companies that possess some of the best fundamentals in the field, big and small, from pharmaceutical giants to geriatric care specialists.

IN PICTURES: 8 Great Companies With Top-Notch Healthcare Benefits

Outpacing All Relevant Averages

One of the world's biggest drug companies is Pfizer (NYSE: PFE), possessing a market cap approaching $132 billion. After bottoming a month ago with the general market, Pfizer's shares have climbed over 15%. That outpaces both the broader healthcare sector, as represented by the Health Care SPDR ETF (NYSE: XLV), which has risen just over 5% over the same period, and the SPDR S&P 500 ETF (NYSE: SPY), which has climbed 10%. Pfizer trades with a P/E ratio of 13 and offers a dividend yield of 4.4%.

The company was recently embarrassed at the hands of the Food and Drug Administration (FDA), which admonished the drug giant for a dozen violations of agency rules. A letter was sent to Pfizer executives outlining the need to report adverse reactions from its products to the agency within a specified time period.

Strong Five-Year Growth Rate

Sanofi-Aventis SA (NYSE: SNY) is a Paris-based, global pharmaceutical giant with a market cap in excess of $80 billion. The company operates primarily in the field of vaccines for both humans and animals. SNY stock has climbed 4% since the market bottom of a month ago and pays a dividend of 4.8%. P/E on the stock is 11, and Price-to-Book (P/B) ratio is 1.15. For the last five years, SNY has grown sales at a rate of 14.34%.

National HealthCare Corp. (NYSE: NHC) operates 76 long-term health and assisted living centers, primarily in the southeastern United States. In the last month the stock has climbed 3%. It pays an annual 3.2% dividend and trades with a one-year trailing earnings multiple of 14.5. P/B on the stock is a mere 1.32, and price-to-sales ratio is just 0.71.

The Wrap

The best healthcare stocks are those with the fundamentals behind them. Should the broad market finally find its legs, look for the above three issues to lead the healthcare pack higher. (To learn more, see Investing In The Healthcare Sector.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Stock Analysis

    Starbucks: Profiting One Cup at a Time (SBUX)

    Starbucks is everywhere. But is it a worthwhile business? Ask the shareholders who've made it one of the world's most successful companies.
  2. Stock Analysis

    How Medtronic Makes Money (MDT)

    Here's the story of an American medical device firm that covers almost every segment in medicine and recently moved to Ireland to pay less in taxes.
  3. Investing News

    Latest Labor Numbers: Good News for the Market?

    Some economic numbers are indicating that the labor market is outperforming the stock market. Should investors be bullish?
  4. Investing News

    Stocks with Big Dividend Yields: 'It's a Trap!'

    Should you seek high yielding-dividend stocks in the current investment environment?
  5. Investing News

    Should You Be Betting with Buffett Right Now?

    Following Warren Buffett's stock picks has historically been a good strategy. Is considering his biggest holdings in 2016 a good idea?
  6. Products and Investments

    Cash vs. Stocks: How to Decide Which is Best

    Is it better to keep your money in cash or is a down market a good time to buy stocks at a lower cost?
  7. Investing News

    Who Does Cheap Oil Benefit? See This Stock (DG)

    Cheap oil won't benefit most companies, but this retailer might buck that trend.
  8. Investing

    How to Ballast a Portfolio with Bonds

    If January and early February performance is any guide, there’s a new normal in financial markets today: Heightened volatility.
  9. Stock Analysis

    Performance Review: Emerging Markets Equities in 2015

    Find out why emerging markets struggled in 2015 and why a half-decade long trend of poor returns is proving optimistic growth investors wrong.
  10. Investing News

    Today's Sell-off: Are We in a Margin Liquidation?

    If we're in market liquidation, is it good news or bad news? That party depends on your timeframe.
RELATED FAQS
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>
COMPANIES IN THIS ARTICLE
Trading Center